Discontinuous deletions at 11q23 in B cell chronic lymphocytic leukemia

Leukemia

Volumn 13, Issue 5, 1999, Pages 708-712

  Zhu, Y ^a   Monni, O ^a   El Rifai, W ^b,c   Siitonen, S M ^d   Vilpo, L ^d   Vilpo, J ^d   Knuutila, S ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NATIONAL RESEARCH CENTRE   (Egypt)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

B cell chronic lymphocytic leukemia; Deletions at 11q23; Fluorescence in situ hybridization; Yeast artificial chromosome

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CHROMOSOME 11Q; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; PRIORITY JOURNAL; YEAST ARTIFICIAL CHROMOSOME;

EID: 0033013993     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401405     Document Type: Article

References (30)

1. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, lsaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84: 1361-1392.
2. Autio K, Elonen E, Teerenhovi L, Knuutila S. Cytogenetic and immunologic characterization of mitotic cells in chronic lymphocytic leukemia. Eur J Haematol 1987; 39: 289-298.
3. Larramendy ML, Siitonen SM, Zhu Y, Hurme M, Vilpo L, Vilpo JA, Knuutila S for the Tampere CLL group. Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia - significance for cytogenetic analysis. Cytogenet Cell Genet 1998; 82: 215-221.
4. Döhner H, Stilgenbauer S, Kröber A, Schröder M, Döhner K, Bentz M, Lichter P. Chromosome aberrations identify prognostic subgroups of chronic lymphocytic leukemia. Conference abstract 'B Cell Lymphoproliferative Disorders' 1998; Imedex USA.
5. Fegan C, Robinson H, Thompson P, Whittaker JA, White D. Karyotypic evolution in CLL. Identification of a new subgroup of patients with deletions of 11q and advanced or progressive disease. Leukemia 1995; 9: 2003-2008.
6. Hernandez JM, Mecucci C, Criel A, Meeus P, Michaux L, van Hoof A, Verhoef G, Louwagie A, Scheiff JM, Michaux JL, Boogaerts M, van den Berghe H. Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria. Leukemia 1995; 9: 2140-2146.
7. Döhner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M, Fischer K, Hunstein W, Lichter P. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997; 89: 2516-2522.
8. Karhu R, Knuutila S, Kallioniemi OP, Siitonen S, Aine R, Vilpo L, Vilpo J. Frequent loss of the 11q14-q24 region in chronic lymphocytic leukemia - a study by comparative genomic hybridization. Genes Chromosomes Cancer 1997; 19: 286-290.
9. Johansson B, Mertens F, Mitelman F. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromosomes Cancer 1993; 8: 205-218.
10. Hampton GM, Mannermaa A, Winquist R, Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newsham I, Cavenee WK, Evans GA. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res 1994; 54: 4586-4589.
11. Foulkes WD, Campbell IG, Stamp GWH, Trowsdale J. Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer. Br J Cancer 1993; 67: 268-273.
12. Hampton GM, Penny LA, Baergen RN, Larson A, Brewer C, Liao S, Busby-Earle RMC, Williams AWR, Steel CM, Bird CC, Stanbridge EJ, Evans GA. Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci USA 1994; 91: 6953-6957.
13. Keldysh PL, Dragani TA, Fleischman EW, Konstantinova LN, Perevoschikov AG, Pierotti MA, Della Porta G, Kopnin BP. 11q deletions in human colorectal carcinomas: cytogenetics and restriction fragment length polymorphism analysis. Genes Chromosomes Cancer 1993; 6: 45-50.
14. Tomlinson IPM, Gammack AJ, Stickland JE, Mann GJ, MacKie RM, Kefford RF, McGee JOD. Loss of heterozygosity in malignant melanoma at loci on chromosome 11 and 17 implicated in pathogenesis of other cancers. Genes Chromosomes Cancer 1993; 7: 169-172.
15. Devilee P, van Schothorst EM, Bardoel AFJ, Bonsing B, Kuipers-Dijkshoorn N, James MR, Fleuren G, van der Mey AGL, Cornelisse CJ. Allelotype of head and neck paragangliomas: allelic imbalance is confined to the long arm of chromosome 11, the site of the predispoing locus PGL. Genes Chromosomes Cancer 1994; 11: 71-78.
16. Chen P, Lin HH, Weissman BE. A functional analysis of tumor suppressor activity for peripheral neuroepitheliomas by chromosome transfer. Oncogene 1995; 10: 577-586.
17. Gioeli D, Conway K, Weissman BE. Localization and characterization of a chromosome 11 tumor suppressor gene using organotypic raft cultures. Cancer Res 1997; 57: 1157-1165.
18. Stilgenbauer S, Liebisch P, James MR, Schröder M, Schlegelberger B, Fischer K, Bentz M, Lichter P, Döhner H. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders. Proc Natl Acad Sci USA 1996; 93: 11837-11841.
19. Rai KR, Sawitsky A, Chronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219-234.
20. Binet JL, Auquier A, Digihiero C, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198-206.
21. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol 1989; 42: 567-584.
22. General Haematology Task Force of BCSH. Immunophenotyping in the diagnosis of chronic lymphoproliferative disorders. J Clin Pathol 1994; 47: 871-075.
23. Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640-1645.
24. Arai V, Hosoda F, Nakayama K, Ohki M. A yeast artificial contig and Notl restriction map that spans the tumor suppressor gene(s) locus, 11q22.2-q23.3. Genomics 1996; 35: 196-206.
25. Hoffman C, Winston F. A ten minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 1987; 57: 267-272.
26. Pinkel D, Straume T, Gray J. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1986; 83: 2934-2938.
27. Monni O, Zhu Y, Franssila K, Oinonen R, Elonen E, Höglund P, Joensuu H, Knuutila S. Molecular characterization of the deletion at 11q22.1-q23.3 in mantle cell lymphoma. Br J Haematol 1999; 104: 665-671.
28. Laake K, Ødegård Å, Andersen TI, Bukholm IK, Kåresen R, Nesland JM, Ottestad L, Shiloh Y, Børresen-Dale A-L. Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromosomes Cancer 1997; 18: 175-180.
29. Wolf M, Aaltonen LA, Szymanska J, Tarkkanen M, Blomqvist C, Berner JM, Myklebost O, Knuutila S. Complexity of 12q13-22 amplicon in liposarcoma: microsatellite repeat analysis. Genes Chromosomes Cancer 1997; 18: 66-70.
30. Wang S, Esplin E, Li J, Huang L, Gazdar A, Minna J, Evans G. Alterations of the PPP2R1B gene in human lung and colon cancer. Science 1998; 282: 284-287.